Cardiff Oncology公布在ASH 2025中与Onvansertib联合进行的慢性骨髓单核细胞白血病的临床试验数据
Cardiff Oncology公布在ASH 2025中与Onvansertib联合进行的慢性骨髓单核细胞白血病的临床试验数据
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.